Results 31 to 40 of about 33,349 (194)

Knowledge among college students and employees of local health units about human papillomavirus and cervical cancer and its implications for public health strategies and vaccination

DST, 2022
Introduction: Human papillomavirus (HPV) is the most commonly diagnosed sexually transmitted infection worldwide. It is estimated that 70% of cervical cancer cases are related to high-risk HPV 16 and 18 types; and 90% of genital warts to HPV 6 and 11 ...
Edison Natal Fedrizzi, Walkíria Rodrigues de Freitas, Fabiana Gonçalves de Aguiar   +2 more
doaj  

Plant Virus Immunotherapy for HPV‐Associated Oropharyngeal Squamous Cell Carcinoma

Advanced NanoBiomed Research, EarlyView.
Cowpea mosaic virus (CPMV) nanoparticles are safe and potent cancer immunotherapy candidates with strong immunomodulatory activity. CPMV activates innate immunity, which in turn drives adaptive immune responses and promotes durable, systemic antitumor effects.
Jessica Fernanda Affonso de Oliveira, Patrick Opdensteinen, Andrea Simms, Seongwon Jung, Giuliana P. Mognol, Hui Chen, Judith A. Varner, Nicole F. Steinmetz   +7 more
wiley   +1 more source

Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation.

PLoS ONE
Human papillomavirus 16 and human papillomavirus 18 have been associated with different life-threatening cancers, including cervical, lung, penal, vulval, vaginal, anal, and oropharyngeal cancers, while cervical cancer is the most prominent one.
Md Mijanur Rahman, Md Habib Ullah Masum, Rehana Parvin, Shuvo Chandra Das, Asma Talukder   +4 more
doaj   +1 more source

Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents

BMC Public Health, 2017
Background Human papillomavirus (HPV) vaccine coverage rates remain low. This is believed to reflect parental hesitancy, but few studies have examined how changes in parents’ attitudes impact HPV vaccine uptake.
Jeffrey J. VanWormer, Casper G. Bendixsen, Elizabeth R. Vickers, Shannon Stokley, Michael M. McNeil, Julianne Gee, Edward A. Belongia, Huong Q. McLean   +7 more
doaj   +1 more source

An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy

Frontiers in Immunology, 2022
Human papillomavirus (HPV) is the most common sexually transmitted agent worldwide. Early prevention with HPV vaccination is a safe and effective method against this disease.
Zahra Yousefi, Hamid Aria, Farhoodeh Ghaedrahmati, Tahereh Bakhtiari, Mahdieh Azizi, Reza Bastan, Reza Hosseini, Nahid Eskandari   +7 more
doaj   +1 more source

What Makes an “Ideal” Cell Line for Recombinant Adeno‐Associated Virus Production?

Biotechnology and Bioengineering, EarlyView.
Several host cell types have been used to produce rAAVs to date. Cell line‐specific traits that are beneficial in the context of rAAV manufacturing are reviewed here, with the goal of developing a consensus on the ‘ideal’ characteristics that an rAAV production host should possess (created with Biorender.com).
James Conheady, Nicholas Donohue, Alexandra Bogdanovic, Sharon Davin, Brian Glennon, Niall Barron, C. Mark Smales   +6 more
wiley   +1 more source

Human Papillomavirus Vaccination – A Moment of Prevention, a Lifetime of Protection

Indian Journal of Public Health
Human papillomavirus (HPV) vaccination is the primary preventive strategy to reduce the burden of cervical cancer as well as other HPV-related malignancies.
Priya Abraham
doaj   +1 more source

Obstacles to Implementing the HPV Vaccine: Is it Worth Pursuing or Not?

Asian Pacific Journal of Cancer Care, 2019
Cervical cancer, along with breast, colorectal, and lung cancer, has become increasingly problematic in Malaysia. The prevalence of cervical cancer in Malaysia is projected to rise in younger women, and Malaysia views this prediction with concern and ...
Mastura Mohd Sopian, Sharifah Azdiana Tuan Din, Hasmah Hussin   +2 more
doaj   +1 more source

Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs

Frontiers in Oncology, 2022
Human papillomavirus (HPV) contributes to sexually transmitted infection, which is primarily associated with pre-cancerous and cancerous lesions in both men and women and is among the neglected cancerous infections in the world.
Rahul Bhattacharjee, Lamha Kumar, Archna Dhasmana, Tamoghni Mitra, Abhijit Dey, Sumira Malik, Bonglee Kim, Rohit Gundamaraju   +7 more
doaj   +1 more source

Extended High‐Risk HPV Genotyping With BD Onclarity Enhances Anal Cancer Screening Among High‐Risk Populations: A Cross‐Sectional Study

Diagnostic Cytopathology, EarlyView.
ABSTRACT Background Anal cancer rates are rising among women, immunocompromised individuals, and Men who have sex with Men (MSM), independent of HIV status. While high‐resolution anoscopy remains the diagnostic standard, limited access has increased interest in alternative screening.
Daisy Maharjan, Joshua Waters, Melissa Randolph, Benjamin Shuler, Julie Borum, Sheila Segura   +5 more
wiley   +1 more source